liposuction surgery devices Report Share and Growth 2024-2032

The global liposuction surgery devices market is experiencing significant growth, with a value of US$ 1,701.0 million in 2023 and an expected CAGR of 11.87% from 2024 to 2032, reaching US$ 4,668.0 million by 2032. Liposuction surgery, a cosmetic procedure aimed at removing excess fat deposits, has seen a surge in demand driven by societal emphasis on physical appearance and the increasing number of individuals seeking toned bodies.
Key Market Trends and Drivers:
• Increase in Cosmetic Surgical Procedures: The growing number of cosmetic surgeries globally, including liposuction, is driving the demand for liposuction surgery devices. Media visibility and celebrity endorsements play a significant role in boosting the popularity of liposuction as a favored cosmetic procedure.
• Rise in Cases of Obesity: The global increase in obesity rates is fueling the demand for liposuction surgery devices. Obesity triggers individuals to seek solutions for weight management and body contouring, driving the growth of the market.
• Growing Disposable Income and Rise in Medical Tourism: Rising disposable incomes and the growth of medical tourism are expected to fuel the global liposuction surgery devices market. Higher incomes enable more people to afford cosmetic procedures like liposuction, while medical tourism offers competitive prices and advanced facilities.
• Rapid Growth of Ultrasound-assisted Liposuction: Ultrasound-assisted liposuction is one of the fastest-growing segments in the global market due to its effectiveness and safety. It uses ultrasound energy to liquefy fat cells before extraction, offering smoother results with less trauma to surrounding tissues.

Request For Sample Report:
United States Liposuction Surgery Devices Market: The United States is a prominent player in the global market, driven by its advanced healthcare infrastructure and societal emphasis on physical appearance. The presence of top medical device manufacturers and innovative technologies further cements its leading position in shaping the global market.
Company News:
• SOLTA MEDICAL (Bausch Health Companies, Inc.): The FDA cleared The Renuvion APR handpiece for coagulating subcutaneous soft tissues after liposuction for aesthetic body contouring.
• InMode Ltd.: Acquired Body Sculpt International, a renowned provider of body contouring surgeries, to expand its minimally invasive liposuction procedures.
• Genesis Biosystems, Inc.: Innovated a novel liposuction method named OrthoSculpt, focusing on removing fat around muscular structures to achieve a natural athletic physique.
• Hologic Inc.: Launched Morpheus8, an advanced fractional radiofrequency microneedling device designed to reduce fat and tighten skin and wrinkles in body and facial areas.
Market Segmentation:
• Product Type: Stand-alone Liposuction Surgery Devices, Portable Liposuction Surgery Devices
• Technology: Tumescent Liposuction, Ultrasound-Assisted Liposuction, Laser-Assisted Liposuction, Power-Assisted Liposuction, Water-Assisted Liposuction, Suction-Assisted Liposuction, Others
• Country: North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Key Players:
1. SOLTA MEDICAL (Bausch Health Companies, Inc.)
2. InMode Ltd.
3. Genesis Biosystems, Inc.
4. Hologic Inc.
5. Apyx Medical
6. Cynosure Inc.
7. YOLO Medical Inc.
8. Sciton Inc.
In conclusion, the global liposuction surgery devices market is witnessing significant growth driven by the increase in cosmetic surgical procedures, rise in cases of obesity, growing disposable income, and the rapid growth of ultrasound-assisted liposuction. The market is expected to continue growing, presenting opportunities for key players to innovate and expand their product offerings.

About the Company:
Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:
Renub Research
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Share the Post:

Related Posts